Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies

被引:206
作者
Sole, Brisa [1 ]
Jimenez, Esther [1 ]
Torrent, Carla [1 ]
Reinares, Maria [1 ]
del Mar Bonnin, Caterina [1 ]
Torres, Imma [1 ]
Varo, Cristina [1 ]
Grande, Iria [1 ]
Valls, Elia [1 ]
Salagre, Estela [1 ]
Sanchez-Moreno, Jose [1 ]
Martinez-Aran, Anabel [1 ]
Carvalho, Andre F. [2 ]
Vieta, Eduard [1 ]
机构
[1] Univ Barcelona, Hosp Clin, Barcelona Bipolar Disorders Program, Inst Neurosci,IDIBAPS,CIBERSAM, Barcelona, Catalonia, Spain
[2] Univ Fed Ceara, Fac Med, Translat Psychiat Res Grp, Fortaleza, Ceara, Brazil
关键词
cognitive impairment; bipolar disorder; cognitive remediation; functional remediation; N-ACETYL CYSTEINE; DIRECT-CURRENT STIMULATION; MAJOR DEPRESSIVE DISORDER; DOUBLE-BLIND; EUTHYMIC PATIENTS; SOCIAL COGNITION; FUNCTIONAL REMEDIATION; NEUROCOGNITIVE FUNCTION; EXECUTIVE FUNCTIONS; ALCOHOL DEPENDENCE;
D O I
10.1093/ijnp/pyx032
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Over the last decade, there has been a growing appreciation of the importance of identifying and treating cognitive impairment associated with bipolar disorder, since it persists in remission periods. Evidence indicates that neurocognitive dysfunction may significantly influence patients' psychosocial outcomes. An ever-increasing body of research seeks to achieve a better understanding of potential moderators contributing to cognitive impairment in bipolar disorder in order to develop prevention strategies and effective treatments. This review provides an overview of the available data from studies examining treatments for cognitive dysfunction in bipolar disorder as well as potential novel treatments, from both pharmacological and psychological perspectives. All these data encourage the development of further studies to find effective strategies to prevent and treat cognitive impairment associated with bipolar disorder. These efforts may ultimately lead to an improvement of psychosocial functioning in these patients.
引用
收藏
页码:670 / 680
页数:11
相关论文
共 120 条
[1]   Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study [J].
Alda, Martin ;
McKinnon, Margaret ;
Blagdon, Ryan ;
Garnham, Julie ;
MacLellan, Susan ;
O'Donovan, Claire ;
Hajek, Tomas ;
Nair, Cynthia ;
Dursun, Serdar ;
MacQueen, Glenda .
BRITISH JOURNAL OF PSYCHIATRY, 2017, 210 (01) :54-60
[2]   The impact of cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study [J].
Amoretti, S. ;
Bernardo, M. ;
Bonnin, C. M. ;
Bioque, M. ;
Cabrera, B. ;
Mezquida, G. ;
Sole, B. ;
Vieta, E. ;
Torrent, C. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (10) :1638-1648
[3]   Cognitive reserve in bipolar disorder: relation to cognition, psychosocial functioning and quality of life [J].
Anaya, C. ;
Torrent, C. ;
Caballero, F. F. ;
Vieta, E. ;
del Mar Bonnin, C. ;
Ayuso-Mateos, J. L. .
ACTA PSYCHIATRICA SCANDINAVICA, 2016, 133 (05) :386-398
[4]  
[Anonymous], EUR NEUROPSYCHOPHARM
[5]  
[Anonymous], PSIQUIATRIA BIOL
[6]   Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives [J].
Arts, B. ;
Jabben, N. ;
Krabbendam, L. ;
van Os, J. .
PSYCHOLOGICAL MEDICINE, 2008, 38 (06) :771-785
[7]   Neurocognitive endophenotypes (Endophenocognitypes) from studies of relatives of bipolar disorder subjects: A systematic review [J].
Balanza-Martinez, Vicent ;
Rubio, Cristina ;
Selva-Vera, Gabriel ;
Martinez-Aran, Anabel ;
Sanchez-Moreno, Jose ;
Salazar-Fraile, Jose ;
Vieta, Eduard ;
Tabares-Seisdedos, Rafael .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2008, 32 (08) :1426-1438
[8]   Neurocognition in bipolar disorders-A closer look at comorbidities and medications [J].
Balanza-Martinez, Vicent ;
Selva, Gabriel ;
Martinez-Aran, Anabel ;
Prickaerts, Jos ;
Salazar, Jose ;
Gonzalez-Pinto, Ana ;
Vieta, Eduard ;
Tabares-Seisdedos, Rafael .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 626 (01) :87-96
[9]   A review on the impact of cognitive dysfunction on social, occupational, and general functional outcomes in bipolar disorder [J].
Baune, Bernhard T. ;
Malhi, Gin S. .
BIPOLAR DISORDERS, 2015, 17 :41-55
[10]   N-acetyl cysteine for depressive symptoms in bipolar disorder - A double-blind randomized placebo-controlled trial [J].
Berk, Michael ;
Copolov, David L. ;
Dean, Olivia ;
Lu, Kristy ;
Jeavons, Sue ;
Schapkaitz, Ian ;
Anderson-Hunt, Murray ;
Bush, Ashley I. .
BIOLOGICAL PSYCHIATRY, 2008, 64 (06) :468-475